Royalty Pharma
RPRX
#620
Rank
A$58.78 B
Marketcap
A$102.24
Share price
-0.01%
Change (1 day)
68.65%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): A$2.23

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is A$2.28. In 2025 the company made an earnings per share (EPS) of A$2.66 a decrease over its 2024 EPS that were of A$2.87.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.23-16.21%
2025A$2.66-7.1%
2024A$2.87
2020A$2.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
A$4.03 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.99 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$7.71 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA